LifePath RPM
Remote patient monitoring for chronic disease and population health, built on our FDA 510(k)-cleared platform.
Solutions
Connected monitoring for hospitals, cardiology programs, and chronic-care clinics.
Three clearly differentiated solutions across chronic disease management and ambulatory cardiac monitoring. Each is designed for clinical use, with safety, effectiveness, compliance, and medical-device standards built into our approach.
Three solutions
Clearly positioned by use case and market.
LifePath-C (US)
Wearable 6/12-lead ambulatory ECG monitor being developed for the US market. Under FDA 510(k) review.
LifePath-C (International)
Wearable 6/12-lead ECG monitor with expanded AI/ML cardiac analysis and multi-parameter monitoring for selected international markets.
Why two LifePath-C pages?
Different market requirements. Clearly separated capabilities.
LifePath-C is presented in separate US and international versions because cardiac monitoring capabilities and regulatory requirements differ by market. The US version reflects the capabilities and claims associated with the FDA regulatory pathway, while the international version reflects expanded capabilities available in selected markets where they are appropriately licensed.
Category comparison
How Elastic Care compares.
| Category | Elastic Care | Common alternative |
|---|---|---|
| RPM | Device-agnostic | Proprietary hardware |
| Cardiac monitoring | Wearable 6/12-lead | Limited-lead wearables |
| Review workflow | Structured clinical review with AI-assisted analysis | Retrospective review |
| Monitoring operations | Internal, or optional managed service in selected international markets | Software only |
| Regulatory posture | FDA 510(k)-cleared RPM platform plus active FDA pathway for LifePath-C | Consumer-grade |
Comparisons are category-level.